₹-0.02
(Market cap
₹26 Cr
Recently Viewed
Clear AllMarket cap
₹26 Cr
Revenue (TTM)
₹6 Cr
P/E Ratio
--
P/B Ratio
0.4
Div. Yield
0 %
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
₹0 Cr
ROE
0.4 %
ROCE
0.6 %
Industry P/E
16.09
EV/EBITDA
-97.1
Debt to Equity
0
Book Value
₹1.6
EPS
₹-0
Face value
1
Shares outstanding
398,624,000
CFO
₹4.16 Cr
EBITDA
₹15.00 Cr
Net Profit
₹15.58 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Shree Bio-Tech
| 4.8 | 16.1 | 4.8 | -31.6 | -16.8 | -36.0 | -- |
|
BSE FMCG
| -7.0 | 11.4 | -0.2 | -10.2 | 3.7 | 8.4 | 9.2 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Shree Bio-Tech
| -41.0 | -39.2 | 20.8 | -79.0 | 23.5 | -8.6 | -2.4 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE FMCG
| -2.1 | 1.5 | 27.3 | 16.6 | 9.3 | 10.5 | -3.6 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Shree Bio-Tech
|
0.7 | 25.9 | 5.9 | -0.3 | -33.2 | -0.4 | -- | 0.4 |
| 265.3 | 1,329.7 | 1,378.9 | 101.1 | 9.9 | 13.5 | 13.2 | 1.9 | |
| 165.6 | 3,444.9 | 1,463.4 | 73.6 | 6.1 | 16.3 | 46.9 | 6.6 | |
| 244.0 | 289.3 | 493.3 | 4.4 | 0.5 | 2.7 | 69.9 | 1.7 | |
| 937.2 | 4,837.8 | 1,377.9 | 300.8 | 20.1 | 18.3 | 16.1 | 2.7 | |
| 420.1 | 14,579.4 | 10,267.2 | 636.9 | 9.0 | 16.2 | 22.4 | 3.4 | |
| 4.7 | 502.2 | 1,440.2 | 343.1 | 24.1 | 32.2 | 1.5 | 0.4 | |
| 169.1 | 323.0 | 445.5 | 43.1 | 9.9 | 5.9 | 7.5 | 0.5 | |
| 272.5 | 302.5 | 14.1 | 1.1 | 7.5 | 18.1 | 285.9 | 43.8 | |
| 4.0 | 491.8 | 1,312.7 | 33.1 | 5.1 | 8.6 | 14.9 | 1.0 |
No Review & Analysis are available.
Growing of plants for planting
Incorporated
1982
Chairman
--
Managing Director
--
Headquarters
Kolkata, West Bengal
Website
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
The share price of Shree Ganesh Bio-Tech (India) Ltd is ₹0.65 (BSE) as of 24-Apr-2026 IST. Shree Ganesh Bio-Tech (India) Ltd has given a return of -16.83% in the last 3 years.
Since, TTM earnings of Shree Ganesh Bio-Tech (India) Ltd is negative, P/E ratio is not available.
The P/B ratio of Shree Ganesh Bio-Tech (India) Ltd is 0.41 times as on 24-Apr-2026, a 78 discount to its peers’ median range of 1.86 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
128.57
|
0.57
|
|
2024
|
67.31
|
0.66
|
|
2023
|
19.96
|
0.65
|
|
2022
|
36.70
|
3.07
|
|
2021
|
37.29
|
4.09
|
The 52-week high and low of Shree Ganesh Bio-Tech (India) Ltd are Rs 0.96 and Rs 0.54 as of 26-Apr-2026.
Shree Ganesh Bio-Tech (India) Ltd has a market capitalisation of ₹ 26 Cr as on 24-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Shree Ganesh Bio-Tech (India) Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.